DATE | HS_CODE | Product Description | Trademark | Country | Net Weight | Statistical Cost | Place | Shipper Name | Consignee Name |
---|
2017-09-04 | 2935909000 | "Torasemide system stability" working standards NOT DRUG, POWDER, reference material for examination of active pharmaceutical ingredients, FOR LABORATORY WILL NOT APPLY FOR THE PREVENTION, DIAGNOSIS, TREATMENT | *** | FRANCE | 0 | 98,74 | *** | ***** | ***** |
2017-09-07 | 2933599500 | Standart pharmacopeia sample (reference sample): norfloxacin CRS system stability ARTICLE Y0001015 (5 vials of 10 mg). CAS 70458-96-7. Chemical name: 1-ETHYL-6-FLUORO-1,4-dihydro-4-oxo-7- (1-piperazinyl) -3-quinolinecarbonyl SM. ADVANCED: OL | *** | FRANCE | 0 | 479,56 | *** | ***** | ***** |
2017-09-11 | 2936290001 | Vitamin B9 and its derivatives; Vitamin H and its derivatives ROVIMIKS BIOTIN / ROVIMIX BIOTIN - FOR ENRICHMENT OF DIETS FOR ANIMAL biotin. Powder from white to slightly yellowish, has good flowability, reduced dust formation, solution B | *** | FRANCE | 1300 | 23191,65 | *** | ***** | ***** |
2017-09-25 | 2933399900 | "Clopidogrel system stability" working standards NOT DRUG, POWDER, reference material for examination of active pharmaceutical ingredients, FOR LABORATORY WILL NOT APPLY FOR THE PREVENTION, DIAGNOSIS, TREATMENT | *** | FRANCE | 0 | 198,85 | *** | ***** | ***** |
2017-09-25 | 2933599500 | "Mirtazapine system stability" working standards NOT DRUG, POWDER, reference material for examination of active pharmaceutical ingredients, FOR LABORATORY WILL NOT APPLY FOR THE PREVENTION, DIAGNOSIS, TREATMENT | *** | FRANCE | 0 | 198,85 | *** | ***** | ***** |
2017-09-25 | 2934999000 | "Zidovudine system stability" working standards NOT DRUG, POWDER, reference material for examination of active pharmaceutical ingredients, FOR LABORATORY WILL NOT APPLY FOR THE PREVENTION, DIAGNOSIS, TREATMENT | *** | FRANCE | 0 | 293,5 | *** | ***** | ***** |
2017-09-25 | 2934999000 | "Risperidone system stability" working standards NOT DRUG, POWDER, reference material for examination of active pharmaceutical ingredients, FOR LABORATORY WILL NOT APPLY FOR THE PREVENTION, DIAGNOSIS, TREATMENT | *** | FRANCE | 0 | 482,8 | *** | ***** | ***** |
2017-10-01 | 2933299000 | "Losartan system stability" working standards NOT DRUG, POWDER, STANDARD MODEL FOR EXAMINATION PROVEDENIYA active pharmaceutical ingredients, LABORATORNYH__1.0__ TO BE APPLIED FOR THE PREVENTION, DIAGNOSIS, LE | ABSENT | FRANCE | 1E-06 | 566,3 | MOSCOW | ***** | ***** |
2017-10-23 | 2933299000 | "Losartan system stability" working standards NOT DRUG, POWDER, reference material for examination of active pharmaceutical ingredients, LABORATORNYH__1.0__ TO BE APPLIED FOR THE PREVENTION, DIAGNOSIS, LE | ABSENT | FRANCE | 1E-06 | 566,18 | MOSCOW | ***** | ***** |
2017-10-23 | 2931908009 | "Alendronate sodium system stability" working standards NOT DRUG, POWDER, reference material for examination of active pharmaceutical ingredients, LABORATORNYH__1.0__ TO BE APPLIED FOR THE PREVENTION, Diag | ABSENT | FRANCE | 1E-05 | 193,14 | MOSCOW | ***** | ***** |